or Try an Advanced Search...

    Technical Analysis for BBLG - Bone Biologics Corp

    Grade Last Price % Change Price Change
    F 1.19 -7.75% -0.10
    BBLG closed down 7.75 percent on Friday, November 15, 2024, on 3 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical BBLG trend table...
    Date Alert Name Type % Chg
    Stochastic Buy Signal Bullish 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Bullish Engulfing Bullish -7.75%
    Pocket Pivot Bullish Swing Setup -7.75%
    Wide Bands Range Expansion -7.75%
    Oversold Stochastic Weakness -7.75%
    Narrow Range Bar Range Contraction 0.85%
    Earnings Movers Other 0.85%
    Wide Bands Range Expansion 0.85%
    Older End-of-Day Signals for BBLG ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown 1 day ago
    Possible Inside Day 1 day ago
    Down 5% 1 day ago
    10 DMA Resistance 1 day ago
    Down 3% 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    BBLG Chart by TradingView
    Basic chart:

    Profile

    Bone Biologics Corp Description

    Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. Its platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

    Classification
    Sector: Healthcare
    Industry: Medical Devices
    Keywords: Biopharmaceutical Clinical Medicine Surgery Neurosurgery Platform Technology Orthopedic Surgery Sports Medicine Surgical Specialties Spinal Fusion Degenerative Disc Disease

    Is BBLG a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 21 Bone Biologics Appoints Phillip T. Meikle to its Board of Directors
    Sep 17 Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
    Aug 28 LifeNet launches newest bone allograft gel with Johnson & Johnson
    Aug 12 Bone Biologics files to sell 1.62M shares of common stock for holders
    Aug 12 BBLG: Controls Costs and Advances Trials
    Aug 2 Bone Biologics to raise $2.1M through exercise of warrants
    Aug 2 Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds
    Jul 11 OTC Markets Hosts Virtual Investor Presentation with Jeff Frelick, CEO and President of Bone Biologics, and Deina Walsh, CFO, with Brad Sorensen, Senior Analyst at Zacks SCR
    Jun 20 First patients treated in Bone Biologics spinal fusion trial
    Jun 20 First Two Patients Treated in Pilot Clinical Study with Bone Biologics’ NB1 Bone Graft Device in Spine Fusion
    See more BBLG news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 10.56
    52 Week Low 0.8
    Average Volume 3,862,544
    200-Day Moving Average 1.85
    50-Day Moving Average 1.64
    20-Day Moving Average 1.44
    10-Day Moving Average 1.28
    Average True Range 0.19
    RSI (14) 39.02
    ADX 15.04
    +DI 20.91
    -DI 24.14
    Chandelier Exit (Long, 3 ATRs) 1.74
    Chandelier Exit (Short, 3 ATRs) 1.70
    Upper Bollinger Bands 1.91
    Lower Bollinger Band 0.98
    Percent B (%b) 0.23
    BandWidth 64.38
    MACD Line -0.13
    MACD Signal Line -0.12
    MACD Histogram -0.0149
    Fundamentals Value
    Market Cap 635.74 Thousand
    Num Shares 534 Thousand
    EPS -13.52
    Price-to-Earnings (P/E) Ratio -0.09
    Price-to-Sales 0.00
    Price-to-Book 0.44
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.46
    Resistance 3 (R3) 1.47 1.40 1.41
    Resistance 2 (R2) 1.40 1.33 1.39 1.40
    Resistance 1 (R1) 1.29 1.29 1.26 1.28 1.38
    Pivot Point 1.22 1.22 1.20 1.21 1.22
    Support 1 (S1) 1.11 1.15 1.08 1.10 1.00
    Support 2 (S2) 1.04 1.11 1.03 0.98
    Support 3 (S3) 0.93 1.04 0.97
    Support 4 (S4) 0.92